News|Articles|August 19, 2026
Ensuring Sample Integrity from Discovery to Post-Market Surveillance
Author(s)Mesa Labs
An educational article examining how continuous environmental monitoring protects sample integrity across every phase of the drug development lifecycle, from discovery and preclinical research through clinical trials and post-market surveillance.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers
2
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
3
Andelyn Biosciences Partners with Queen's University on GM2 Gangliosidosis Gene Therapy
4
Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing
5